GMRE – 8-K March 3, 2026 In SEC https://www.sec.gov/Archives/edgar/data/1533615/000110465926022515/0001104659-26-022515-index.htm #GMRE Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) AUB – 8-K